Inova Pharmaceuticals (Singapore) is backed by private equity and has undergone investment activity.
Alternatives.pe tracks Inova Pharmaceuticals (Singapore)'s investment history, valuation trends, ownership structure, and transaction activity over time.
Last Updated: 2026-08-05
Browse all uploaded documents here
Company FY 2022
Audited Financial Statement
ViewSeller (Valeant Pharmaceuticals) FY 2017
Audited Financial Statement
ViewExplore the latest updates and insights
TPG and others acquire iNova Pharmaceuticals
Pacific Equity Partners and The Carlyle Group acquired iNova Pharmaceuticals
Valeant Pharmaceuticals acquires iNova Pharmaceuticals
Archer Capital and Ironbridge Capital acquired APAC and Africa operations of 3M Pharmaceuticals